← Glossary / Medications
Bone Health Glossary · Medications

Romosozumab

Also called: Evenity

Evidence
◆ Strong Clinical Evidence
Topic
Medications
Taught in
Tier 2 · Lesson 7
In plain English

What it means

Romosozumab (brand name Evenity) is an anabolic osteoporosis medication given by injection that blocks sclerostin, a signal that normally holds bone formation back, allowing new bone to be built.

Why it matters for your bones

Understanding how this medication works helps you have an informed conversation with your prescriber about whether it fits your bone-building plan.

Romosozumab, sold as Evenity, belongs to the anabolic family of osteoporosis medications, alongside teriparatide and abaloparatide. Rather than slowing down the cells that break down bone, it works by blocking sclerostin — the same signaling molecule that osteocytes normally release to put the brakes on bone formation. By blocking that signal, romosozumab frees osteoblasts to build new bone tissue.

This mechanism is interesting because it's conceptually closest to what mechanical loading does in the body biologically, since loading also reduces sclerostin signaling naturally. Anabolic agents like romosozumab tend to produce larger bone density gains than antiresorptive drugs, which is part of why they are typically reserved for people at higher risk.

Romosozumab is time-limited by design, usually used for 12 to 24 months, and the gains it produces aren't self-sustaining on their own — standard practice is to follow it with an antiresorptive medication to help hold onto the bone that was built. It also carries a cardiovascular warning, which makes careful patient selection important. Any decision about starting, continuing, or switching from this medication belongs with your prescriber, who can weigh your individual risk factors.

Evidence

How sure is this?

The research behind this
Strong Clinical Evidence

Graded Strong Clinical Evidence: Supported by multiple well-designed clinical studies in humans. Read each study with its grade in mind. One study is a piece of the picture, not the whole of it.

2 peer-reviewed studies, free with an Academy login
Go deeper

Where the Academy teaches it

This page is the short version. The lessons teach it in full, with the context around it and a quiz to lock it in.

Keep going

Related words

Anabolic bone agent
Strong Clinical Evidence

Anabolic bone agents are medications, like teriparatide, abaloparatide, and romosozumab, that stimulate the body to…

Teriparatide
Strong Clinical Evidence

Teriparatide (Forteo) is a daily injected medication that stimulates bone-building cells to form new bone, rather…

Abaloparatide
Strong Clinical Evidence

Abaloparatide (Tymlos) is a daily injectable medication that stimulates bone-building cells to form new bone, used…

Sclerostin
Established Science

Sclerostin is a protein made by bone cells called osteocytes that blocks new bone formation; less mechanical strain…

Antiresorptive
Established Science

Antiresorptive medications, like bisphosphonates and denosumab, slow down the cells that break down old bone,…

Bisphosphonate
Strong Clinical Evidence

Bisphosphonates are osteoporosis medications — like alendronate, risedronate, and zoledronic acid — that slow down…

Education only, not medical advice. Decisions about tests, medications and treatment belong with your own doctor. OsteoStrong does not diagnose, treat or cure any disease.

Keep learning

More ways in